Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines.
about
Long-term decrease in VLA-4 expression and functional impairment of dendritic cells during natalizumab therapy in patients with multiple sclerosisAbsence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitisInflammation in the nervous system: the human perspective.Cytokines in multiple sclerosis: methodological aspects and pathogenic implications.Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis.Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies.CCR5Δ32 Polymorphism Associated with a Slower Rate Disease Progression in a Cohort of RR-MS Sicilian Patients.Microglia use multiple mechanisms to mediate interactions with vitronectin; non-essential roles for the highly-expressed αvβ3 and αvβ5 integrinsNeural stem cells in inflammatory CNS diseases: mechanisms and therapy.The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitisCytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis.Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.Microglia are the major source of TNF-α and TGF-β1 in postnatal glial cultures; regulation by cytokines, lipopolysaccharide, and vitronectin.A novel method to establish microglia-free astrocyte cultures: comparison of matrix metalloproteinase expression profiles in pure cultures of astrocytes and microgliaThe human microbiome in multiple sclerosis: pathogenic or protective constituents?Association of CCR5 delta32 deletion with early death in multiple sclerosis.Adult human mesenchymal cells proliferate and migrate in response to chemokines expressed in demyelination.Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis.Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects.Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse.Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions.Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia.Insights into abnormal sphingolipid metabolism in multiple sclerosis: targeting ceramide biosynthesis as a unique therapeutic strategy.Expression of chemokine receptors in the different clinical forms of multiple sclerosis
P2860
Q28730755-D10E0CBB-7066-431D-81D8-3FAB48581A70Q28755978-56ADA948-A183-4AE7-8A19-417036DC8AC4Q34398679-B23ADE05-F148-408D-A79D-B9FAB88E708BQ34924266-338DD91D-1C18-4D17-824F-CD3D640706E3Q34963755-C3AC4313-5914-4D43-869D-C5C151F28CA5Q35094706-0979A4DC-F88E-415E-AB90-12E9134853C4Q35367491-90854142-4B2C-446F-97E6-36512FBEB7DFQ35618230-9D110768-FACC-464B-A088-E8CAD774C77EQ36166488-948AB4CC-C854-4669-97E2-24FCC7A3EBC9Q36399022-A60CABEE-8058-4629-87D8-22A6A9AB9311Q36403041-009A4AEF-9EF2-4EE4-A3C1-E3293D96D118Q36734084-CC64DA6D-0AC1-41B0-B7F8-FBF6165FE50EQ37286371-C4210687-2BE6-41D6-8831-8FF78A1D7035Q37418389-7718EBD7-3D47-4B88-BC20-18B65BC6A129Q37830018-27E694E4-1E33-4377-A815-6015C03F4481Q39015230-83E9247F-A36A-43CC-9F6D-79E01D7D1E33Q42735915-DA0D0ACE-CDFA-4024-96C4-9953553699C7Q43849905-F8C78E4E-FA18-43D8-A34F-27906F74D380Q43907854-B0F2293E-8790-45BB-BC83-C1FD648AB647Q44412466-47A954C7-2C81-4A76-9847-91749C1F7285Q48651342-49FCC550-2526-4714-BF94-C7795E5C9D4DQ48777649-9BE1AC77-780D-47F5-81DD-DF1889430F66Q48892536-E0B1461B-2DB0-4FB9-91B8-4F233693A4C7Q51621205-9D6A2767-B2DB-4CD6-A6C3-C434B18F7EEAQ54461005-701E0809-0F9E-4F8F-90B7-9EDA7A1DC772Q57602047-36CBFD15-5DE5-410E-B6AF-91E8CC56F41B
P2860
Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines.
@ast
Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines.
@en
type
label
Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines.
@ast
Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines.
@en
prefLabel
Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines.
@ast
Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines.
@en
P1476
Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines.
@en
P2093
Ransohoff RM
P356
10.1016/S0165-5728(99)00082-X
P577
1999-07-01T00:00:00Z